US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
The US Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables. The third BD Simplist product to be introduced includes Ondansetron ...
The US Food and Drug Administration (FDA) has approved BD Rx's second injectable antiemetic, BD Simplist Metoclopramide Injection, USP. BD Simplist prefilled injectables are designed to enhance patient care and safety by minimizing the ...
Becton, Dickinson and Company (BD) has announced the FDA approval of first drug, diphenhydramine hydrochloride injection, USP, to be offered in BD Simplist line of prefilled generic injectables. Diphenhydramine Hydrochloride Injection, ...
Tags: FDA, drug, prefilled generic injectables
Mylan Institutional business has won final FDA approval for its abbreviated new drug application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100mg/ml, packaged in 200mg/2ml multiple-dose vials. Mylan is shipping the ...